By personalizing your treatment plan, we can help you continue making progress and maintain long-term results through a balanced, medically guided approach
First Four Weeks Initial Retatrutide effects typically appear within the first week of dosing
doi: 10.1002/dmrr.1080 95 LauJBlochPSchfferLPetterssonISpetzlerJKofoedJet al
Food & Drug Administration (2021) Insulin resistance, Cleveland Clinic (2021) The potential role of incretin-based therapies for polycystic ovary syndrome: A narrative review of the current evidence, Sage Journals (2021) Impact of obesity on infertility in women, Journal of the Turkish-German Gynecological Association (2015) Semaglutide treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs, Journal of Clinical Medicine (2023) Semaglutide vs metformin in polycystic ovary syndrome (PCOS), Clinicaltrials.gov (2024) Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes, Diabetes Car e (2012) Liraglutide for weight management: a critical review of the evidence, Obesity Science and Practice (2017) Polycystic ovary syndrome: Common questions and answers, American Family Physician (2023) Insulin resistance in polycystic ovarian syndrome, Cureus ( 2022) Hirsutism, Mayo Clinic (2021) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Given these emerging connections and in partnership with Reuters , we wanted to better understand the real-world overlap between people using GLP-1 RA medications and those diagnosed with PCOS
Side Effects Unique to Women on Retatrutide The standard side effect profile nausea, GI changes, injection site reactions affects men and women similarly
